StockStory.org on MSN
Remitly’s (NASDAQ:RELY) Q3 Sales Top Estimates But Stock Drops 13.3%
Online money transfer platform Remitly (NASDAQ:RELY) announced in Q3 CY2025, with sales up 24.7% year on year to $419.5 million. On the other hand, next quarter’s revenue guidance of $427 million was ...
Aspiring rare-earths miner Ramaco Resources is raising capital via convertible debt. That pressured its stock early Wednesday ...
Stocks like USA Rare Earth and MP Materials are being pushed up and down on news flow from trade negotiations.
Rocket Companies is rated a Buy, driven by strong financial momentum, strategic acquisitions, and positive macroeconomic ...
The US housing market faces a turning point. As elevated mortgage rates, limited inventory, and the Fed’s shifting policy ...
Shares of Sarepta Therapeutics declined after it swung to a third-quarter loss and reported two of its therapies didn't meet statistical significance in a recent trial. The stock slid 36% to $15.67 in ...
Rare earth stocks are trading lower Monday after the White House announced that China will lift its rare earth mineral export restrictions.
Rein Therapeutics shares rise after the FDA lifts clinical hold on its Phase 2 RENEW trial for idiopathic pulmonary fibrosis treatment LTI-03.
The five-year deal, valued at roughly $9.7 billion, includes a 20% prepayment and marks a significant step in IREN’s expansion into large-scale artificial intelligence (AI) infrastructure. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results